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Abstract
We have previously shown that the L1 major capsid protein of low-risk HPV11 binds to the Kap 2 adapter and enters the nucleus via
a Kap 21-mediated pathway. In this study, we discovered that HPV11 L1 capsomeres bind to Kap 2 import receptor, known to mediate
nuclear import of hnRNP A1 via interaction with its nuclear localization signal termed M9. Significantly, binding of HPV11 L1 capsomeres
to Kap 2 inhibited the nuclear import of Kap 2, and its specific M9-containing cargo. Interestingly, HPV11 L1 capsomeres also interacted
with Kap 3 import receptor and inhibited Kap 3 nuclear import. Moreover, the L1 capsomeres of high-risk HPV-16 shared these
activities. These data suggest that HPV L1 major capsid proteins interact with Kap 2 and Kap 3, and they may inhibit the Kap 2- and
Kap 3-mediated nuclear import pathways during the productive phase of the viral life cycle when the virions are assembled and released.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Human papillomaviruses (HPVs) are nonenveloped, ico-
sahedral DNA tumor viruses that infect squamous epithelial
cells of either anogenital and oral mucosal tissues or the
skin. Mucosal HPVs have demonstrated varying degrees of
oncogenic potential: high-risk HPVs, types 16, 18, 31, and
45, are frequently detected in invasive cervical carcinomas,
whereas the low-risk HPVs, types 6 and 11, are associated
with benign exophytic condylomas (zur Hausen, 2000). The
virion particles (52-55 nm in diameter) consist of a single
molecule of 8-kb double-stranded circular DNA packaged
into a spherical capsid composed of 72 homopentameric L1
capsomeres and 12 molecules of L2 minor capsid protein
(Trus et al., 1997). During the productive, vegetative am-
plification phase of the viral life cycle in terminally differ-
entiated epithelial cells, the newly synthesized L1 major
capsid proteins enter the nuclei and together with the L2
minor capsid proteins package the replicated HPV genomic
DNA into infectious virions. L1 major capsid proteins can
self-assemble both in vivo and in vitro into capsid-like
structures, referred to as virus-like particles (VLPs) (Belnap
et al., 1996; Hagensee et al., 1994; Kirnbauer et al., 1992;
Rose et al., 1993; Volpers et al., 1994; Zhou et al., 1993).
The VLPs can be disassembled quantitatively into L1 ho-
mopentameric capsomeres by an agent that reduces disul-
fide bonds and can be reassembled by removing the reduc-
ing agent (Li et al., 1998; McCarthy et al., 1998).
The general mechanism for nuclear import is that a cargo
interacts in the cytoplasm either directly or via an adapter
with an import receptor belonging to the karyopherin /im-
portin  (Kap /Imp ) superfamily, is transported through
the nuclear pore complex, and is released inside the nucleus
(Moroianu, 1999; Nakielny and Dreyfuss, 1999; Wente,
2000). All Kap s shuttle between the nucleus and the
cytoplasm and bind to nucleoporins at the nuclear pore
complex and to the GTPase Ran in its GTP bound form.
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Binding of nuclear RanGTP to Kap s (importins) causes
the dissociation of the import complexes with release of the
cargoes inside the nucleus. In vertebrates, several members
of the Kap  superfamily have been identified and shown to
function in nuclear import of specific cargoes. Kap 1/
Importin  can function together with a Kap /importin 
adapter in nuclear import of proteins that contain classic
monopartite or bipartite nuclear localization signals (NLSs),
or without adapters in import of ribosomal proteins, cyclin
B1, and several viral proteins, or together with Imp7 in
import of histone H1 (Moroianu, 1999; Nakielny and Drey-
fuss, 1999; Wente, 2000). Mammalian Kap 2/transportin
mediates nuclear import of hnRNP A1 and A2 via interac-
tion with their Gly/Asn-rich NLS termed M9, of hnRNP F
(Bonifaci et al., 1997; Pollard et al., 1996; Siomi and Drey-
fuss, 1995; Siomi et al., 1997), of an mRNA export factor
called TAP (Truant et al., 1999), and of ribosomal proteins
(Yaseen and Blobel, 1997; Jakel and Gorlich, 1998). Inter-
estingly, the ribosomal proteins L23a, S7, and L5 can in-
teract with four Kaps, Kap 1, Kap 2/transportin, Kap
3/Imp5, and Imp7, and be imported alternatively by these
Kaps (Yaseen and Blobel, 1997; Jakel and Gorlich, 1998).
We have previously shown that the L1 capsomeres of
HPV types 11, 16, and 45 can efficiently enter the nucleus
in the presence of cytosol containing the karyopherins,
whereas the intact capsids (50–55 nm) cannot pass through
the nuclear pore complexes which have a functional diam-
eter of 39 nm (Merle et al., 1999; Nelson et al., 2000, 2002).
Moreover, we had established that the L1 capsomeres of
both low-risk HPV11 and high-risk HPV-16 and -45 enter
the nucleus via a classical Kap 21-mediated pathway
(Merle et al., 1999; Nelson et al., 2000, 2002). Interestingly,
we recently discovered that the L1 capsomeres of high-risk
HPV-16 and -45 interact with Kap 2 import receptor and
inhibit the nuclear import of Kap 2, and of a Kap 2-
specific M9-containing cargo (Nelson et al., 2002). This
novel interaction of high-risk HPV L1 capsid proteins with
Kap 2 raised several questions: (1) do the low-risk HPV
L1 proteins (e.g., type 11) share this activity, (2) do L1
proteins of both low- and high-risk HPVs interact with other
members of Kap  superfamily, and 3) if they do, what are
the consequences of these interactions?
In this study we found that the L1 capsomeres of low-
risk HPV11 interact with Kap 2 import receptor and bind-
ing of RanGTP to Kap 2 does not dissociate the HPV11
L1–Kap 2 complex. Significantly, binding of HPV11 L1
capsomeres to Kap 2 inhibited the nuclear import of Kap
2, and of a Kap 2-specific M9-containing cargo. Inter-
estingly, HPV11 L1 capsomeres also interacted with Kap
3 import receptor and inhibited Kap 3 nuclear import.
Moreover, these activities were shared by the L1 capso-
meres of high-risk HPV16. Together, these data suggest that
during the productive phase of viral life cycle, when the
HPV L1 major capsid proteins enter the nucleus via a
classical Kap 21-mediated pathway to assemble the viri-
ons, they also interact with Kap 2 and Kap 3 and may
thereby inhibit the Kap 2- and Kap 3-mediated nuclear
import of host proteins.
Results
HPV11 L1 capsomeres interact with Kap 2 and inhibit
the Kap 2-mediated nuclear import pathways
We have previously shown that the L1 major capsid
protein of low-risk HPV11 interacts with Kap 2 adapter
and enters the nucleus via a classical Kap 21-mediated
pathway (Merle et al., 1999).
In this study, we found that HPV11 L1 capsomeres
bound to the Kap 2 nuclear import receptor (Fig. 1A, Lane
1). As a control, HPV11 L1 capsomeres did not bind to
glutathione-S-transferase (GST) alone (Fig. 1A, Lane 3).
Binding of RanGTP to Kap s inhibits their interaction with
specific cargoes (Moroianu, 1999; Wente, 2000), and, as
expected, RanGTP was efficient in inhibiting the interaction
between Kap 2 and M9-GST (Fig. 1B, compare Lanes 1
and 2). In contrast, binding of RanGTP to Kap 2 did not
inhibit the interaction between HPV11 L1 capsomeres and
Kap 2 (Fig. 1A, compare Lanes 1 and 2).
Analysis of HPV11 L1 amino acid sequence does not
reveal any M9-like motif, suggesting a different type of
interaction between the Kap 2 and HPV11 L1. Indeed, we
found that HPV11 L1 capsomeres can bind to Kap 2 at the
same time Kap 2 interacts with M9-GST (Fig. 1B, Lane 3).
As a control, HPV11 L1 capsomeres did not bind to the
M9-GST alone (Fig. 1B, Lane 4). These data indicate that
the two binding sites on Kap 2 for the M9 signal and
HPV11 L1 are distinct and separate.
The interaction between HPV11 L1 capsomeres and Kap
2 lead us to investigate if HPV11 L1 capsomeres can enter
into the nucleus via a Kap 2-mediated pathway. Therefore,
Fig. 1. HPV11 L1 capsomeres interact with Kap 2. (A) Immobilized
GST-Kap 2 was incubated at RT for 30 min with either HPV11 L1
capsomeres alone (Lane 1), or the L1 capsomeres plus RanGTP (Lane 2).
As a specificity control, HPV11 L1 capsomeres were incubated with
immobilized GST (Lane 3). (B) Immobilized M9-GST was incubated at
RT for 30 min with either Kap 2 (Lane 1), Kap 2 plus RanGTP (Lane
2), Kap 2 plus HPV11 L1 capsomeres (Lane 3), or HPV11 L1 capsomeres
alone (Lane 4). Bound proteins were eluted with sample buffer and ana-
lyzed by SDS–PAGE and Coomassie blue staining.
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digitonin-permeabilized HeLa cells were incubated with
either HPV11 L1 capsomeres or M9-GST (positive control
for Kap 2 pathway) in the presence of either Kap 2 plus
RanGDP or HeLa cytosol. We found that Kap 2 did not
mediate nuclear import of HPV11 L1 capsomeres, whereas,
as expected, it did mediate the nuclear import of the M9-
GST control (Fig. 2, compare A and C). In the presence of
cytosol, both the HPV11 L1 capsomeres and the M9-GST
entered the nucleus (Figs. 2B and 2D).
As Kap 2 did not mediate nuclear import of HPV11 L1
capsomeres, we next investigated if binding of HPV11 L1 to
Kap 2 inhibits nuclear import of Kap 2. Digitonin-per-
meabilized HeLa cells were incubated with GST-Kap 2 in
the absence or presence of HPV11 L1 capsomeres. As
expected, GST-Kap 2 entered the nucleus in the absence of
HPV11 L1 capsomeres (Fig. 3A). In the presence of HPV11
L1 capsomeres, nuclear import of GST-Kap 2 was
strongly inhibited (Fig. 3, compare A and B), indicating that
binding of HPV11 L1 capsomeres to Kap 2 interferes with
nuclear import of Kap 2. Moreover, we have found that in
the presence of HPV11 L1 capsomeres, Kap 2-mediated
nuclear import of its specific M9-GST cargo was inhibited
(Fig. 3, compare C and D). These results suggest that
HPV11 L1 capsomeres do not use Kap 2 to enter into the
nucleus via an additional pathway, instead they inhibit Kap
2 nuclear import and consequently, the Kap 2 mediated
import pathways.
Significantly, we found that in the presence of cytosol
containing the karyopherins (Kap 2, Kap 1, and Kap 2),
HPV11 L1 capsomeres could both efficiently enter the nu-
cleus, via a Kap 21-mediated pathway (Fig. 4A), and
inhibit the Kap 2-mediated nuclear import of M9-GST
(Fig. 4, compare B and C).
HPV11 L1 capsomeres interact with Kap 3 and inhibit
Kap 3 nuclear import
The binding of HPV11 L1 capsomeres to Kap 2 raised
the possibility of interactions with additional Kap  import
receptors. Indeed, we discovered that HPV11 L1 capso-
meres also bound to the Kap 3 immobilized on Gluta-
thione–Sepharose but not to the GST alone (Fig. 5, Lanes 1
and 3). Binding of RanGTP to Kap 3 did not inhibit the
interaction between HPV11 L1 capsomeres and Kap 3
(Fig. 5, compare Lanes 1 and 2).
Investigation of nuclear import of HPV11 L1 capso-
meres in the presence of Kap 3 plus RanGDP revealed that
Kap 3 was unable to mediate nuclear import of HPV11 L1
(data not shown). These results led us to investigate if
binding of HPV11 L1 capsomeres to Kap 3 inhibits its
nuclear import. Therefore, digitonin-permeabilized HeLa
Fig. 2. Kap 2 does not mediate nuclear import of HPV11 L1 capsomeres.
Digitonin-permeabilized HeLa cells were incubated for 30 min at RT with
either HPV11 L1 capsomeres (A and B) or GST-M9 (C and D) in the
presence of either Kap 2 plus RanGDP (A and C) or HeLa cytosol (B and
D). HPV11 L1 capsomeres were detected with a specific polyclonal anti-
body to HPV11 L1, and M9-GST, with a polyclonal antibody to GST.
Fig. 3. HPV11 L1 capsomeres inhibit nuclear import of Kap 2- and Kap
2-mediated import of M9-GST. Digitonin-permeabilized HeLa cells were
incubated for 30 min at RT with either GST-Kap 2 (A) or a mixture of
GST-Kap 2 and HPV11 L1 capsomeres that had been preincubated for 30
min before import (B). Nuclear import of GST-Kap 2 was detected with
a monoclonal anti-GST antibody. Digitonin-permeabilized HeLa cells were
incubated for 30 min at RT with either Kap 2M9-GST RanGDP (C)
or with Kap 2  M9-GST  RanGDP in the presence of HPV11 L1
capsomeres (in equimolar amount to the Kap 2) (D). Nuclear import of
M9-GST was detected with a monoclonal anti-GST antibody.
Fig. 4. In the presence of cytosol, HPV11 L1 capsomeres can both enter the
nucleus via Kap 21-mediated pathway and inhibit Kap 2-mediated
nuclear import of M9-GST. Digitonin-permeabilized cells were incubated
with HPV11 L1 capsomeres  cytosol (A), M9-GST  cytosol (B), or
M9-GST  cytosol  HPV11 L1 capsomeres (C). Detection was done
with an anti-HPV11 L1 antibody (A) or with an anti-GST antibody (B
and C).
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cells were incubated with GST-Kap 3 plus RanGDP in the
absence or presence of HPV11 L1 capsomeres. Nuclear
docking and import of GST-Kap 3 was strongly inhibited
in the presence of HPV11 L1 capsomeres (Fig. 6, compare
A and B), indicating that binding of HPV11 L1 capsomeres
to Kap 3 interferes with these processes.
Kap 2 competes with Kap 2 and Kap 3 for binding to
HPV11 L1 capsomeres
In competition assays, we found that Kap 2 can reduce
the binding of HPV11 capsomeres to either Kap 2 or Kap
3 (Figs. 7A and 7B, compare Lanes 1 and 2). Note that
Kap 2 also bound to other available molecules in the
homopentameric L1 capsomeres (unbound to either Kap 2
or Kap 3) (Figs. 7A and 7B, Lane 2). The competition data
suggest that the affinity of HPV11 L1 capsomeres for Kap
2 is higher than for Kap 2 or Kap 3. This is in agree-
ment with the efficient nuclear import of HPV11 L1 cap-
someres in the presence of cytosol containing all the Kaps
(Fig. 4).
The L1 capsomeres of high-risk HPV16 also interact with
Kap 3 and inhibit Kap 3 nuclear import
We had previously found that HPV16 L1 capsomeres
interact with Kap 2 and inhibit nuclear import of Kap 2
(Nelson et al., 2002). The interaction between the L1 cap-
someres of low-risk HPV11 and Kap 3 raised the question
if this is true also for HPV16. In solution, binding assays
demonstrated that HPV16 L1 capsomeres interacted with
GST-Kap 3 (Fig. 8, Lane 1) and not with GST alone (Fig.
8, Lane 3). Incubation of GST-Kap 3 with HPV16 L1
capsomeres in the presence of RanGTP did not reduce the
binding of L1 capsomeres to Kap 3 (Fig. 8, Lane 2).
Investigation of nuclear import of HPV16 L1 capso-
meres in digitonin-permeabilized cells in the presence of
Kap 3 plus RanGDP revealed that Kap 3 did not mediate
nuclear import of HPV16 L1 capsomeres (data not shown).
As Kap 3 did not mediate nuclear import of HPV16 L1
capsomeres, we next investigated if binding of HPV16 L1
capsomeres to Kap 3 inhibits nuclear import of Kap 3.
Digitonin-permeabilized cells were incubated with GST-
Kap 3 plus RanGDP in the absence or presence of HPV16
L1 capsomeres. We found that indeed HPV16 L1 capso-
meres inhibited nuclear docking and import of GST-Kap 3
Fig. 5. HPV11 L1 capsomeres interact with Kap 3 nuclear import recep-
tor. Immobilized GST-Kap 3 was incubated at RT for 30 min with either
HPV11 L1 capsomeres alone (Lane 1) or the L1 capsomeres plus RanGTP
(Lane 2). As a specificity control, HPV11 L1 capsomeres were incubated
with immobilized GST (Lane 3). Bound proteins were eluted with sample
buffer and analyzed by SDS–PAGE and Coomassie blue staining.
Fig. 6. HPV11 L1 capsomeres inhibit nuclear import of Kap 3. Digitonin-
permeabilized HeLa cells were incubated with GST-Kap 3 plus RanGDP
in the absence (A) or presence of HPV11 L1 capsomeres (B). Detection
was with anti-GST polyclonal antibody.
Fig. 7. Kap 2 competes with Kap 2 and Kap 3 for binding to HPV11
L1 capsomeres. (A) Immobilized GST-Kap 2 was incubated at RT for 30
min with either HPV11 L1 capsomeres alone (Lane 1) or the L1 capsom-
eres plus Kap 2 (Lane 2). (B) Immobilized GST-Kap 3 was incubated
at RT for 30 min with either HPV11 L1 capsomeres alone (Lane 1) or the
L1 capsomeres plus Kap 2 (Lane 2). As a specificity control, HPV11 L1
capsomeres were incubated with immobilized GST (Lane 3). Bound pro-
teins were eluted with sample buffer and analyzed by SDS–PAGE and
Coomassie blue staining.
Fig. 8. HPV16 L1 capsomeres interact with Kap 3 nuclear import recep-
tor. Immobilized GST-Kap 3 was incubated at RT for 30 min with either
HPV16 L1 capsomeres alone (Lane 1) or the L1 capsomeres plus RanGTP
(Lane 2). As a specificity control, HPV16 L1 capsomeres were incubated
with immobilized GST (Lane 3). Bound proteins were eluted with sample
buffer and analyzed by SDS–PAGE and Coomassie blue staining.
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(Fig. 9, compare A and B). In the same conditions, HPV16
L1 capsomeres had no effect on nuclear docking and import
of GST-Kap 1 (data not shown). This is in agreement with
our previous data that HPV16 L1 capsomeres enter the
nucleus via a classical Kap 21-mediated pathway (Nel-
son et al., 2002).
Discussion
We had previously established that the L1 capsomeres of
low-risk HPV11 and high-risk HPV16 interact with Kap 2
adapter and enter the nucleus via a classical Kap 21-
mediated pathway (Merle et al., 1999; Nelson et al., 2002).
In the present study, we have discovered that HPV11 L1
capsomeres can also interact with Kap 2 and Kap 3
nuclear import receptors. Moreover, the L1 capsomeres of
high-risk HPV16 interact with Kap 2 (Nelson et al., 2002)
and Kap 3 (this study). This suggests that the interaction of
L1 capsomeres with both Kap 2 and Kap 3 is a general
property of both low- and high-risk HPVs. Interestingly,
binding of RanGTP to Kap 2 or Kap 3 did not inhibit the
interaction of L1 capsomeres with these Kaps, in contrast
with the role of RanGTP in dissociating import complexes
(Moroianu, 1999; Nakielny and Dreyfuss, 1999). Moreover,
neither Kap 2 nor Kap 3 mediated nuclear import of L1
capsomeres. Recently, Ran binding to Kap 2 has been
uncoupled from cargo dissociation using a TL-Kap 2 mu-
tant, which has a truncated acidic loop (Chook et al., 2002).
Approximately 75% of nuclear import of a specific cargo
was lost with TL-Kap 2 mutant in comparison with the
wild-type Kap 2. These data strongly suggested that at
least 75% of Kap 2-mediated import is dependent on
Ran-mediated cargo dissociation (Chook et al., 2002).
Significantly, the interactions of L1 capsomeres with
Kap 2 and Kap 3 cause inhibition of Kap 2 and Kap 3
nuclear import, and consequently, their nuclear import path-
ways. The main cargoes transported by Kap 2 are hnRNP
A1 and A2 via interaction with their M9 sequence (Bonifaci
et al., 1997; Pollard et al., 1996; Siomi and Dreyfuss, 1995;
Siomi et al., 1997), and a mRNA export factor called TAP
(Truant et al., 1999). hnRNP A1 is an abundant nuclear
RNA-binding protein involved in the processing of pre-
mRNA (Dreyfuss et al., 1993) and its nucleocytoplasmic
shuttling is strongly correlated with nuclear export of ma-
ture mRNAs (Izaurralde et al., 1997). Interestingly, the
stress-induced decrease of nuclear abundance of hnRNP
A/B proteins and increase of their cytoplasmic levels cause
changes in the alternative splicing pattern of an adenovirus
E1A pre-mRNA splicing reporter (van der Houven van
Oordt et al., 2000). It can be speculated that in the produc-
tive, vegetative amplification phase of the viral life cycle,
the interaction of newly synthesized L1 proteins with Kap
2 may inhibit Kap 2-mediated nuclear import of hnRNP
A1 and TAP, and, as a consequence, affect pre-mRNA
splicing and mRNA nuclear export.
As HPV L1 capsomeres are efficiently imported into the
nuclei of digitonin-permeabilized cells in the presence of
HeLa cytosol containing all the Kaps (Merle et al., 1999;
Nelson et al., 2002; this study), the higher affinity interac-
tion of L1 capsomeres is with Kap 21 heterodimers
leading to nuclear import. This is in agreement with the fact
that Kap 2 competes with either Kap 2 or Kap 3 for
binding to HPV L1 capsomeres.
Significantly, HPV11 L1 capsomeres can both efficiently
enter the nucleus via a Kap 21-mediated pathway (Fig.
4A) and inhibit the Kap 2-mediated nuclear import of its
specific M9-GST cargo (Fig. 4, compare B and C). These
data suggest that L1 capsomeres can inhibit Kap 2-medi-
ated nuclear import of cargoes under conditions expected
for infections, when they are efficiently imported into the
nucleus via Kap 21 heterodimers.
The cargoes known so far to be transported by Kap 3
are the ribosomal proteins L23a, S7, and L5 (Jakel and
Gorlich, 1998), and core histones (Muhlhausser et al.,
2001). Both the ribosomal proteins and the core histones can
also enter the nucleus also via Kap 1, Kap 2, and Imp 7
(Jakel and Gorlich, 1998; Muhlhausser et al., 2001). Inhi-
bition of nuclear import of both Kap 2 and Kap 3 by L1
proteins may reduce nuclear import of ribosomal proteins
and/or core histones. However, it cannot be speculated at
this time if this would happen during the productive, veg-
etative amplification phase of the viral life cycle, as both
classes of proteins can enter the nucleus via alternative
pathways (Jakel and Gorlich, 1998; Muhlhausser et al.,
2001) and the stoichiometry of L1 protein levels vs Kap 2
and Kap 3 during viral infection is unknown. Demonstra-
tion of inhibition of Kap 2- and Kap 3-mediated nuclear
import of specific cargoes by L1 capsomeres in vivo under
conditions similar to viral infection would strongly support
the current interpretation of our results. Future studies in
vivo will bring more insight into the role(s) these interac-
tions of L1 capsomeres with Kap 2 and Kap 3 play
during the productive, vegetative amplification phase of the
viral life cycle.
Intact L1 capsids can interact with both Kap 2 and Kap
3 (data not shown), suggesting that the binding sites for
these Kaps are exposed at the capsid surface. Kap 2 in-
Fig. 9. HPV16 L1 capsomeres inhibit nuclear import of Kap 3. Digitonin-
permeabilized HeLa cells were incubated with GST-Kap 3 plus RanGDP
in the absence (A) or presence of HPV16 L1 capsomeres (B). Detection
was with an anti-GST polyclonal antibody.
166 L.M. Nelson et al. / Virology 306 (2003) 162–169
teracts with the C-terminus located classical monopartite or
bipartite NLSs of HPV L1 proteins (Nelson et al., 2000,
2002), whereas Kap 2 and Kap 3 do not (data not
shown). The fact that Kap 2 competes with both Kap 2
and Kap 3 for binding to L1 suggests the possibility that
the binding sites for Kap 2 and Kap 2/Kap 3 may have
some partial overlap. Further studies are required to map the
binding domains between HPV L1 proteins and Kap 2/
Kap 3 and determine the mechanism of inhibition of Kap
2 and Kap 3 nuclear import.
In conclusion, HPV L1 major capsid proteins seem to
have evolved a double strategy: (1) they enter the nucleus
via a classical Kap 21-mediated pathway and together
with the L2 minor capsid proteins package the replicated
viral DNA into virions, and (2) they interact with Kap 2
and Kap 3 import receptors and instead of exploiting these
interactions to enter the nucleus via two additional path-
ways, they may block their nuclear import. Further studies
in vivo are required to understand the role(s) of the inhibi-
tion of Kap 2- and Kap 3-mediated nuclear import path-
ways during the productive phase of viral life cycle when
the virions are formed and released.
Materials and methods
Preparation of recombinant human nuclear import factors
His-tagged Kap 2 (Weis et al., 1995) and His-tagged
Kap 1 (Chi et al., 1996) were expressed in Escherichia coli
BL21(DE3) (3 h induction with 2 mM IPTG at 30°C), and
the soluble His-tagged proteins were purified in their native
state on Talon beads using a standard procedure. GST-Kap
1 (Chi et al., 1996), GST-Kap 2 (Chook and Blobel,
1999), and GST-Kap 3 (Yaseen and Blobel, 1997) were
expressed in E. coli BL21(DE3) (3 h induction with 1 mM
IPTG at 30°C), and the soluble GST-fusion proteins were
purified in their native state on Glutathione–Sepharose
beads using a standard procedure. Kap 2 was obtained by
cleaving the GST-Kap 2 fusion protein, as described (Nel-
son et al., 2002). To obtain Kap 3, the GST-Kap 3 was
incubated for 2 h at RT with biotinylated thrombin, and after
cleavage the GST was removed by binding to Glutathione–
Sepharose beads and the thrombin by binding to Streptavi-
din-containing beads, according to the manufacturer’s pro-
cedures. Human Ran (Coutavas et al., 1993) was prepared
as described (Floer and Blobel, 1996). All proteins were
checked for purity and lack of proteolytic degradation by
SDS–PAGE and Coomassie blue staining. The purified pro-
teins were dialyzed in transport buffer (20 mM HEPES–
KOH, pH 7.3, 110 mM potassium acetate, 2 mM magne-
sium acetate, 1 mM EGTA, 2 mM dithiothreitol, plus
protease inhibitors) and stored in aliquots at 80°C until
use. HeLa cytosol from Cellex Biosciences Inc. was centri-
fuged and stored in aliquots at 80°C.
Preparation of recombinant HPV L1 capsids and
capsomeres
The VLPs of HPV11 and HPV16 were generated in
insect cells, purified as described (Rose et al., 1994a,b), and
stored at 4°C until use. Care is taken during the purification
procedure to isolate primarily intact VLPs. Purity and lack
of proteolytic degradation of L1 proteins were always
checked by SDS–PAGE, Coomassie blue staining, and im-
munoblotting. L1 capsomeres were obtained by incubating
the L1 capsids with 5% mercaptoethanol overnight at 4°C
(McCarthy et al., 1998).
Antibodies
Rabbit polyclonal antisera were raised against HPV L1
capsids as described (Rose et al., 1994a,b). The goat anti-
GST polyclonal antibody was acquired from Amersham
Pharmacia Biotech.
Preparation of M9-GST fusion protein
The M9-GST construct was a gift from Dr. Gideon
Dreyfuss. For protein expression, the construct was used to
transform E. coli BL21 (DE3) bacteria. After induction of E.
coli BL21(DE3) with 1 mM IPTG for 3 h at 37°C, the
M9-GST fusion protein was purified in its native state on
Glutathione–Sepharose using a standard procedure. The pu-
rified protein was checked by SDS–PAGE and Coomassie
blue staining and then dialyzed in buffer A and stored in
aliquots at 80°C until use.
In vitro nuclear import assays
Digitonin-permeabilized HeLa cells have been used by
many labs including ours to investigate different nuclear
import pathways mediated by mammalian Kap s/importins
(Adam and Adam, 1994; Chi et al., 1995; Gorlich et al.,
1995; Kataoka et al., 1999; Merle et al., 1999; Nelson et al.,
2000, 2002; Paschal and Gerace, 1995; Pollard et al., 1996;
Ribbeck et al., 1998, 1999; Schwoebel et al., 1998; Weis et
al., 1995). The nuclear import assays were carried out as
previously described (Nelson et al., 2002). Briefly, subcon-
fluent HeLa cells, grown on poly-l-lysine-coated glass cov-
erslips for 24 h, were permeabilized with 70 g/ml digitonin
for 5 min on ice and washed with transport buffer. Unless
otherwise specified, all import reactions contained an ener-
gy-regenerating system (0.5 mM GTP, 5 mM phosphocre-
atine, and 0.4 U creatine phosphokinase), plus various trans-
port factors (0.5 M Kap 1; 0.5 M Kap 2; 0.5 M Kap
3; 3 M RanGDP), plus the L1 capsomeres (0.25-0.5 M)
or the GST fusion proteins (0.5 M). We also used Kap 2
and Kap 3 as GST-fusion proteins. The presence of GST
in the GST-Kap 2 and GST-Kap 3 fusion proteins does
not interfere with nuclear import of either Kap 2 or Kap
3. Final import reaction volume was adjusted to 20 l with
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transport buffer. For visualization of nuclear import, the
HPV L1 proteins and the GST-fusion proteins were detected
by immunofluorescence with specific antibodies, as previ-
ously described (Merle et al., 1999; Nelson et al., 2000,
2002). The nuclei were identified by DAPI staining. Nuclear
import was analyzed with a Nikon Eclipse TE 300 micro-
scope that has a fluorescence attachment and a Sony DKC-
5000 CCD camera.
In-solution binding assays
GST-Kap 2 or GST-Kap 3 immobilized on Gluta-
thione–Sepharose beads (2 g protein/10 l beads) were
incubated for 30 min under rotation at RT with the HPV L1
capsomeres (2 g protein) in transport buffer containing
0.25% Tween 20 (binding buffer). In some experiments, 2
or 4 g of either Kap 2 or RanGTP were added to the
incubation mixture, as indicated in the figure legends. Con-
trol experiments for binding specificity consisted of incu-
bating GST immobilized on Glutathione–Sepharose beads
with the L1 capsomeres. The bound proteins were eluted
with SDS–PAGE sample buffer and analyzed by SDS–
PAGE followed by Coomassie blue staining.
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